Cite
HARVARD Citation
Saura, C. et al. (2013). Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Ixabepilone or Paclitaxel in Early Stage Breast Cancer and Evaluation of βIII‐Tubulin Expression as a Predictive Marker. Oncologist. pp. 787-794. [Online].